Biology Reference
In-Depth Information
[4] Gerbitz A, Nickoloff BJ, Olkiewicz K, Willmarth NE, Hildebrandt G, Liu C, et al. A role
for tumor necrosis factor-alpha-mediated endothelial apoptosis in the development of
experimental idiopathic pneumonia syndrome. Transplantation 2004;78:494-502.
[5] Sostak P, Reich P, Padovan CS, Gerbitz A, Holler E, Straube A. Cerebral endothelial
expression of adhesion molecules in mice with chronic graft-versus-host disease. Stroke
2004;35:1158-63.
[6] Eissner G, Lindner H, Behrends U, Kolch W, Hieke A, Klauke I, et al. Influence of bacte-
rial endotoxin on radiation-induced activation of human endothelial cells in vitro and
in vivo: protective role of IL-10. Transplantation 1996;62:819-27.
[7] Holler E, Ertl B, Hintermeier-Knabe R, Roncarolo MG, Eissner G, Mayer F, et al. Inflam-
matory reactions induced by pretransplant conditioning—an alternative target for
modulation of acute GvHD and complications following allogeneic bone marrow trans-
plantation? Leuk Lymphoma 1997;25:217-24.
[8] Zeng L, Yan Z, Wang L, Du B, Pan X, Xu K. Irradiation is an early determinant of
endothelial injury during hematopoietic stem cell transplantation. Transplant Proc
2008;40:2661-4.
[9] Samlowski WE, Johnson HM, Hammond EH, Robertson BA, Daynes RA. Marrow abla-
tive doses of gamma-irradiation and protracted changes in peripheral lymph node
microvasculature of murine and human bone marrow transplant recipients. Lab Invest
1987;56:85-95.
[10] Zeng L, Yan Z, Ding S, Xu K, Wang L. Endothelial injury, an intriguing effect of metho-
trexate and cyclophosphamide during hematopoietic stem cell transplantation in mice.
Transplant Proc 2008;40:2670-3.
[11] Zeng L, Jia L, Xu S, Yan Z, Ding S, Xu K. Vascular endothelium changes after condition-
ing in hematopoietic stem cell transplantation: role of cyclophosphamide and busulfan.
Transplant Proc 2010;42:2720-4.
[12] Zoja C, Furci L, Ghilardi F, Zilio P, Benigni A, Remuzzi G. Cyclosporin-induced endothe-
lial cell injury. Lab Invest 1986;55:455-62.
[13] Bruns CJ, Koehl GE, Guba M, Yezhelyev M, Steinbauer M, Seeliger H, et al. Rapamycin-
induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic
therapy against pancreatic cancer. Clin Cancer Res 2004;10:2109-19.
[14] Fujino M, Kim Y, Ito M. Intestinal thrombotic microangiopathy induced by FK506 in rats.
Bone Marrow Transplant 2007;39:367-72.
[15] Woywodt A, Haubitz M, Buchholz S, Hertenstein B. Counting the cost: markers of en-
dothelial damage in hematopoietic stem cell transplantation. Bone Marrow Transplant
2004;34:1015-23.
[16] Palomo M, Diaz-Ricart M, Carbo C, Rovira M, Fernandez-Aviles F, Martine C, et al.
Endothelial dysfunction after hematopoietic stem cell transplantation: role of the
conditioning regimen and the type of transplantation. Biol Blood Marrow Transplant
2010;16:985-93.
[17] Takatsuka H, Wakae T, Mori A, Okada M, Okamoto T, Kakishita E. Effects of total body
irradiation on the vascular endothelium. Clin Transplant 2002;16:374-7.
[18] Holler E, Kolb HJ, Hiller E, Mraz W, Lehmacher W, Gleixner B, et al. Microangiopathy
in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease
after HLA-identical bone marrow transplantation. Blood 1989;73:2018-24.
[19] Oflaz H, Turkmen A, Kazancioglu R, Kayacan SM, Bunyak B, Genchallac H, et al. The
effect of calcineurin inhibitors on endothelial function in renal transplant recipients.
Clin Transplant 2003;17:212-6.
[20] Kalhs P, Brugger S, Schwarzinger I, Greinix HT, Keil F, Kyrle PA, et al. Microangi-
opathy following allogeneic marrow transplantation: association with cyclosporine
and methylprednisolone for graft-versus-host disease prophylaxis. Transplantation
1995;60:949-57.
[21] Paquette RL, Tran L, Landaw EM. Thrombotic microangiopathy following allogeneic
bone marrow transplantation is associated with intensive graft-versus-host disease
prophylaxis. Bone Marrow Transplant 1998;22:351-7.
[22] Cutler C, Kim HT, Ayanian S, Bradwin G, Revta C, Aldridge J, et al. Prediction of veno-
occlusive disease using biomarkers of endothelial injury. Biol Blood Marrow Transplant
2010;16:1180-5.
[23] Janin A, Deschaumes C, Daneshpouy M, Estaquier J, Micic-Polianski J, Rajagopalan-
Levasseur P, et al. CD95 engagement induces disseminated endothelial cell apoptosis
in vivo: immunopathologic implications. Blood 2002;99:2940-7.
[24] Deschaumes C, Verneuil L, Ertault-Daneshpouy M, Adle-Biassette H, Galateau F,
Ainoun F, et al. CD95 ligand-dependent endothelial cell death initiates oral mucosa
damage in a murine model of acute graft versus host disease. Lab Invest 2007;87:417-29.
[25] Yan Z, Zeng L, Jia L, Xu S, Ding S. Increased numbers of circulating ECs are associated
with systemic GVHD. Int J Lab Hematol 2011;33:507-15.
489
Search WWH ::
Custom Search